Cargando…
Biologics in juvenile idiopathic arthritis-main advantages and major challenges: A narrative review
Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in childhood. The disease is divided in different subtypes based on main clinical features and disease course. Emergence of biological agents targeting specific pro-inflammatory cytokines responsible for the disease pathogenesi...
Autores principales: | ADROVIC, Amra, YILDIZ, Mehmet, KÖKER, Oya, ŞAHİN, Sezgin, BARUT, Kenan, KASAPÇOPUR, Özgür |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish League Against Rheumatism
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140868/ https://www.ncbi.nlm.nih.gov/pubmed/34046584 http://dx.doi.org/10.46497/ArchRheumatol.2021.7953 |
Ejemplares similares
-
Juvenile Idiopathic Arthritis
por: Barut, Kenan, et al.
Publicado: (2017) -
Idiopathic Pulmonary Hemosiderosis in a Child with Recurrent Macrophage Activation Syndrome Secondary to Systemic Juvenile Idiopathic Arthritis
por: Barut, Kenan, et al.
Publicado: (2017) -
The impact of COVID-19 on clinical course and treatment among patients with juvenile systemic sclerosis
por: Adrovic, Amra, et al.
Publicado: (2022) -
Juvenile spondyloartropathies
por: Yıldız, Mehmet, et al.
Publicado: (2022) -
Pediatric Behçet's Disease
por: Yildiz, Mehmet, et al.
Publicado: (2021)